Altered fibroblast-like synoviocyte epigenetics is responsible for deficient NUB1 expression in rheumatoid arthritis
Yosuke Ono, Camilla R. L. Machado, Eunice Choi, David L. Boyle, Wei Wang, Gary S. Firestein

TL;DR
This study shows that reduced NUB1 expression in rheumatoid arthritis is due to epigenetic changes in synovial cells, leading to increased inflammation.
Contribution
The novel finding is that defective NUB1 induction in rheumatoid arthritis is caused by an altered epigenetic landscape in fibroblast-like synoviocytes.
Findings
NUB1 expression is reduced in rheumatoid arthritis synovium compared to osteoarthritis tissue.
Epigenetic inhibitors like 5-azacytidine and EPZ6438 can partially or fully restore NUB1 induction in rheumatoid fibroblast-like synoviocytes.
Defective NUB1 induction is linked to increased neddylation and IL-6 expression in rheumatoid synovium.
Abstract
Neddylation is a post-translational modification suppressed by the endogenous inhibitor NUB1, and its dysregulation in rheumatoid arthritis (RA) promotes inflammation and NF-κB activation. NUB1 expression in RA and osteoarthritis (OA) synovium and mechanisms underlying defective NUB1 induction in RA fibroblast-like synoviocytes (FLS) were evaluated. NEDD8 and IL-6 protein expression was increased and NUB1 was reduced in RA synovium compared with OA tissue, with significant differences in the lining region that correlated with higher cytokine expression and NF-kB translocation. IL-1β–induced NUB1 induction was impaired in RA FLS at both the mRNA and protein levels. To evaluate the mechanism, we assessed mRNA stability using actinomycin D, examined the role of SNHG12 by siRNA knockdown, analyzed MAP kinase signaling, and measured NUB1 promoter activity with a luciferase reporter assay.…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 6Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProtein Degradation and Inhibitors · Ubiquitin and proteasome pathways · NF-κB Signaling Pathways
